COVID-19, de novo seizures, and epilepsy: a systematic review.
Ali Akbar Asadi-PooyaLeila SimaniMina ShahisavandiZohreh BarzegarPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
Many PWE perceived significant disruption in the quality of care to them, and some people reported increase in their seizure frequency since the onset of the pandemic. Telemedicine is a helpful technology that may improve access to the needed care for PWE in these difficult times. De novo seizures may occur in people with COVID-19 and they may happen in a variety of forms. In addition to prolonged EEG monitoring, performing a through metabolic investigation, electrocardiogram, brain imaging, and a careful review of all medications are necessary steps. The susceptibility of PWE to contracting COVID-19 should be investigated further.
Keyphrases
- coronavirus disease
- sars cov
- healthcare
- quality improvement
- palliative care
- respiratory syndrome coronavirus
- resting state
- temporal lobe epilepsy
- high resolution
- depressive symptoms
- social support
- physical activity
- mental health
- functional connectivity
- pain management
- white matter
- multiple sclerosis
- photodynamic therapy
- fluorescence imaging
- atomic force microscopy